Stomach Cancer: Interconnection between the Redox State, Activity of MMP-2, MMP-9 and Stage of Tumor Growth

Cancer Microenvironment

Volumn 9, Issue 1, 2016, Pages 27-32

  Burlaka, Anatoly P ^a   Ganusevich, Irina I ^a   Gafurov, Marat R ^b   Lukin, Sergey M ^a,c   Sidorik, Evgeny P ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^c INSTITUTE OF SEMICONDUCTOR PHYSICS   (Ukraine)

Author keywords

Electron paramagnetic resonance (EPR); Electron spin resonance (ESR); Gastric cancer; Matrix metalloproteinases; Metastasis; Reactive oxygen species (ROS); Stomach cancer

Indexed keywords

DNA; GELATINASE A; GELATINASE B; NITRIC OXIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RNA; SUPEROXIDE;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER THERAPY; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; DNA DAMAGE; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ZYMOGRAPHY; PRIORITY JOURNAL; SPIN TRAPPING; STOMACH CANCER; STOMACH CARCINOGENESIS; ZYMOGRAPHY;

EID: 84959080912     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-016-0182-5     Document Type: Article

References (24)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
2. Chissov VI, Starinsky VV, Petrova (2013) Malignant neoplasms in Russia in 2011 (incidence and mortality). Hertzen Research Institute of Oncology, Moscow [in Russian]
3. Fedorenko Z, Goulak LO, Gorokh YL, Ryshov AY, Soumkina OV, Koutsenko LB (2015) Cancer in Ukraine 2013–2014: incidence, mortality, activities of oncological service. Bulletin of national cancer registry of Ukraine vol 16. National Institute of Cancer, Kyiv
4. Sabesan A, Benett JJ (2015) Diagnosis, staging, and workup of gastric cancer. In: Strong VE (ed) Gastric cancer. Springer, Switzerland, pp 127–142
5. Torti SV, Torti FM (2013) Iron and cancer: more ore to be mined. Nat Rev Cancer 13:342–355
6. Elliott RL, Head JF (2012) Cancer: tumor iron metabolism, mitochondrial dysfunction and tumor immunosuppression; “a tight partnership—was Warburg correct?”. J Cancer Ther 3:278–311
7. Burlaka AP, Ganusevich II, Gafurov MR, Lukin SN, Sidorik EP (2013) Electron paramagnetic resonance study of tumor affected bone marrow. Cancer Microenviron 6:273–276
8. Burlaka AP, Sidorik EP, Ganusevich II, Osinsky SP (2006) Effects of radical oxygen species and NO: formation of intra-cellular hypoxia and activation of matrix metalloproteinases in tumor tissues. Exp Oncol 28:49–53
9. Burlaka AP, Sidorik EP, Ganusevich II, Leschenko YM, Osinsky SP (2006) High formation of superoxide anion and nitric oxide, and matrix metalloproteinases activity in vascular wall of rectal carcinoma vessels. Exp Oncol 28:323–325
10. Burlaka AP, Sidorik EP (2006) Radical forms of oxygen and nitrogen oxide in the tumors process. Naukova dumka, Kyiv [in Ukrainian]
11. Gauron C, Rampon C, Bouzaffour M, Ipendey E, Teilon J, Volovitch M, Vriz S (2013) Sustained production of ROS triggers compensatory proliferation and is required for regeneration to proceed. Sci Rep 2084:123–133
12. Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Kalyanamaran B et al (2010) Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. PNAS 107:8788–8793
13. Shimokawa H (2013) Reactive oxygen species promote vascular smooth muscle cell proliferation. Circ Res 113:1040–1042
14. Maeda H (2013) The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect. Cancer Sci 104:779–789
15. Kubben FJ, Sier CF, van Duijn W, Griffioen G, Hanemaaijer R, van de Velde CJ et al (2006) Matrix metalloproteinase–2 is a consistent prognostic factor in gastric cancer. Br J Cancer 94:1035–1040
16. Peña S (2010) Matrix metalloproteases as molecular markers in gastric cancer. Med Clin 134:123–126
17. Wu CY, Wu MS, Chiang EP et al (2007) Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution. Clin Cancer Res 13:2054–2060
18. Chu D, Zhang Z, Li Y et al (2011) Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Int J Cancer 129:887–895
19. Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS 278:16–27
20. Shen W, Xi H, Wei B, Chen L (2014) The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis. J Cancer Res Clin 140:1003–1009
21. Sawada T, Yashiro M, Sentani K, Oue N, Yasui W, Miyazaki K et al (2015) New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicen-ter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee. Gastric Cancer 18:119–128
22. American Joint Committee on Cancer (2010) AJCC cancer staging manual, 7th edn. Springer, New York
23. Burlaka AP, Ganusevich II, Lukin SN, Gafurov MR, Sidorik EP (2014) Superoxide-and NO-dependent mechanisms of the reprogramming of bone marrow cells by tumor cells. Appl Magn Reson 11:1261–1273
24. Burlaka A, Selyuk M, Gafurov M, Lukin S, Potaskalova V, Sidorik E (2014) Changes in mitochondrial functioning with electromagnetic radiation of ultra high frequency as revealed by electron paramagnetic resonance methods. Int J Rad Biol 90:357–362